When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association task force on risk reduction

Scott M Grundy, Gary J. Balady, Michael H. Criqui, Gerald Fletcher, Philip Greenland, Loren F. Hiratzka, Nancy Houston-Miller, Penny Kris-Etherton, Harlan M. Krumholz, John LaRosa, Ira S. Ockene, Thomas A. Pearson, James Reed, Sidney C. Smith, Reginald Washington

Research output: Contribution to journalArticle

137 Scopus citations
Original languageEnglish (US)
Pages (from-to)1683-1685
Number of pages3
JournalCirculation
Volume95
Issue number6
DOIs
StatePublished - Jan 1 1997

Keywords

  • AHA Medical/Scientific Statements
  • cholesterol
  • diet
  • drugs
  • prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., Ockene, I. S., Pearson, T. A., Reed, J., Smith, S. C., & Washington, R. (1997). When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association task force on risk reduction. Circulation, 95(6), 1683-1685. https://doi.org/10.1161/01.CIR.95.6.1683